Today: 10 July 2026
Browse Category

NASDAQ:SKYQ 7 July 2026

Stock Market Today

  • Zenas BioPharma (ZBIO) climbs on positive Phase 3 data after IPO debut
    July 10, 2026, 10:18 AM EDT. Zenas BioPharma Inc. (NASDAQ:ZBIO) said its Phase 3 INDIGO trial for obexelimab cut flare risk by 56% in Immunoglobulin G4-Related Disease, with more than 73% of patients going flare-free for 52 weeks. The biotech presented the results at EULAR 2026 and published them in NEJM. Zenas has now filed a Biologics License Application with the FDA and will share more on a Phase 2 lupus trial soon. Despite this, some investors see AI stocks as offering more upside and less risk than ZBIO right now.
Go toTop